About Us

Microbot Medical receives patent

Microbot Medical Inc. (Nasdaq: MBOT) received a patent for a device that prevents shunt stenosis sending the stock price soaring $2.37 to close at $7.50.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.